These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
969 related articles for article (PubMed ID: 28764929)
1. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929 [TBL] [Abstract][Full Text] [Related]
2. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440 [TBL] [Abstract][Full Text] [Related]
3. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
4. The Evaluation of Effect of Aurora Kinase Inhibitor CCT137690 in Melanoma and Melanoma Cancer Stem Cell. Sogutlu F; Kayabasi C; Yelken BO; Asik A; Gasimli R; Kipcak S; Susluer SY; Avci CB; Gunduz C Anticancer Agents Med Chem; 2021; 21(12):1564-1574. PubMed ID: 33106151 [TBL] [Abstract][Full Text] [Related]
5. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808 [TBL] [Abstract][Full Text] [Related]
6. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598 [TBL] [Abstract][Full Text] [Related]
7. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth. Zhang Y; Ma Y; Wang Y; Mukhopadhyay D; Bi Y; Ji B Pancreatology; 2022 Jun; 22(5):619-625. PubMed ID: 35550115 [TBL] [Abstract][Full Text] [Related]
8. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Ma Y; Li J; Wang H; Chiu Y; Kingsley CV; Fry D; Delaney SN; Wei SC; Zhang J; Maitra A; Yee C Gastroenterology; 2020 Jul; 159(1):306-319.e12. PubMed ID: 32179091 [TBL] [Abstract][Full Text] [Related]
9. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Edderkaoui M; Chheda C; Soufi B; Zayou F; Hu RW; Ramanujan VK; Pan X; Boros LG; Tajbakhsh J; Madhav A; Bhowmick NA; Wang Q; Lewis M; Tuli R; Habtezion A; Murali R; Pandol SJ Gastroenterology; 2018 Dec; 155(6):1985-1998.e5. PubMed ID: 30144430 [TBL] [Abstract][Full Text] [Related]
10. Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells. Furqan M; Huma Z; Ashfaq Z; Nasir A; Ullah R; Bilal A; Iqbal M; Khalid MH; Hussain I; Faisal A Cell Cycle; 2019 Sep; 18(18):2281-2292. PubMed ID: 31318643 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Wang-Bishop L; Chen Z; Gomaa A; Lockhart AC; Salaria S; Wang J; Lewis KB; Ecsedy J; Washington K; Beauchamp RD; El-Rifai W Gastroenterology; 2019 Feb; 156(3):662-675.e7. PubMed ID: 30342037 [TBL] [Abstract][Full Text] [Related]
12. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865 [TBL] [Abstract][Full Text] [Related]
13. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323 [TBL] [Abstract][Full Text] [Related]
14. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer. Mace TA; Shakya R; Elnaggar O; Wilson K; Komar HM; Yang J; Pitarresi JR; Young GS; Ostrowski MC; Ludwig T; Bekaii-Saab T; Bloomston M; Lesinski GB Oncotarget; 2015 Dec; 6(42):44509-22. PubMed ID: 26575024 [TBL] [Abstract][Full Text] [Related]
15. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562 [TBL] [Abstract][Full Text] [Related]
16. OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo. Zhi X; Chen W; Xue F; Liang C; Chen BW; Zhou Y; Wen L; Hu L; Shen J; Bai X; Liang T Oncotarget; 2015 Sep; 6(28):26230-41. PubMed ID: 26213847 [TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777 [TBL] [Abstract][Full Text] [Related]
18. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. He P; Yang JW; Yang VW; Bialkowska AB Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441 [TBL] [Abstract][Full Text] [Related]
19. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530 [TBL] [Abstract][Full Text] [Related]
20. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice. Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]